Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

24th Nov 2016 09:00

RNS Number : 9856P
Exova Group PLC
24 November 2016
 

EXOVA GROUP PLC

Notification of transactions of Directors and PDMRs

 

On 23 November 2016, Paul Barry, a person discharging managerial responsibilities ("PDMR"), exercised the vested portion of a bonus share award granted under the Exova Group plc Deferred Bonus Plan to acquire the number of ordinary shares of 1 pence each ("Shares") in Exova Group plc as set out below with an aggregate exercise price of £1.

1. Name

2. Status

3. Number of Shares under Option exercised

Paul Barry

PDMR

58,824

Following exercise, Paul Barry's total shareholding in the capital of Exova Group plc is 89,900 ordinary shares, representing 0.04 per cent. of the voting share capital of Exova Group plc.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Paul Barry

2.

Reason for the notification

a)

Position/status

PDMR - Group Managing Director, Industries

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Exova Group plc

b)

LEI

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00BKY7HG11

b)

Nature of the transaction

Acquisition of shares following exercise of bonus share award granted under the Exova Group plc Deferred Bonus Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Aggregate exercise price of £1

58,824

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A

 

e)

Date of the transaction

23 November 2016

f)

Place of the transaction

London

 

This notification is made in accordance with Article 19 of the Market Abuse Regulation and the Disclosure and Transparency Rules.

For and on behalf of Exova Group plc

Date: 24 November 2016

Neil MacLennan

General Counsel & Company SecretaryTelephone: 0131 333 8053

 

About Exova

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 138 laboratories and offices in 33 countries and employs more than 4,300 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Automotive; and Health Sciences.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUOONRNSAAUAA

Related Shares:

EXO.L
FTSE 100 Latest
Value8,809.74
Change53.53